Literature DB >> 21709002

Competition between substrates of the efflux pump system of Salmonella enteritidis.

Pedro Cerca1, Ana Martins, Isabel Couto, Miguel Viveiros, Leonard Amaral.   

Abstract

AIM: To determine whether tetracycline competes with ethidium bromide (EB), used as substrate of efflux pumps, for extrusion by the efflux pump system of Salmonella enteritidis NCTC 13349 reference strain.
MATERIALS AND METHODS: Evaluation of efflux of EB in competition with tetracycline was conducted with the aid of an automated EB method and by EB agar method.
RESULTS: The EB agar method demonstrated that the accumulation of EB by S. enteritidis NCTC 13349 reference strain is reduced by high concentrations of tetracycline and that tetracycline accumulates within the cells. The use of the automated EB method confirmed the EB agar results and demonstrated that accumulation of EB is not affected by tetracycline unless the concentration of the antibiotic exceeds 100 mg/l.
CONCLUSION: These results suggest that tetracycline is preferentially retained and that EB is preferentially extruded by the efflux pump of Sientintidis NCTC 13349.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21709002

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  Anti-staphylococcal activity and mode of action of thioridazine photoproducts.

Authors:  Tatiana Tozar; Sofia Santos Costa; Ana-Maria Udrea; Viorel Nastasa; Isabel Couto; Miguel Viveiros; Mihail Lucian Pascu; Mihaela Oana Romanitan
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

2.  The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumannii.

Authors:  Jennifer Nowak; Thamarai Schneiders; Harald Seifert; Paul G Higgins
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

3.  Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them.

Authors:  Leonard Amaral; Ana Martins; Gabriella Spengler; Joseph Molnar
Journal:  Front Pharmacol       Date:  2014-01-03       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.